TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.

Michelle A Kendall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.